Activation of adenylyl cyclase by endogenous Gs-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT7 receptor expression

Molecular Pharmacology

Volumn 69, Issue 1, 2006, Pages 207-215

  Andressen, Kjetil Wessel ^a   Norum, Jens Henrik ^a   Levy, Finn Olav ^a   Krobert, Kurt A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; ECDYSONE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PROSTANOID RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 7 RECEPTOR;

ARTICLE; CELL STRAIN HEK293; CLONE; DESENSITIZATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; STIMULATION; TITRIMETRY;

ADENYLATE CYCLASE; CELL LINE; ENZYME ACTIVATION; HUMANS; KIDNEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROSTAGLANDIN; RECEPTORS, SEROTONIN;

EID: 30044444224     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.015396     Document Type: Article

References (36)

1. 7(a) receptor isoform coupled to adenylate cyclase stimulation. J Pharmacol Exp Ther 287:508-514.
2. 7A receptor by lipidic amphipathic compounds. Mol Pharmacol 60:1349-1355.
3. s-adenylate cyclase interactions. FASEB J 5:2300-2303.
4. 7A receptor. J Biol Chem 273:17469-17476.
5. Black JW and Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141-162.
6. 4 receptors. Curr Drug Targets CNS Neurol Disord 3:39-51.
7. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, et al. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272:22330-22339.
8. s. Receptors Channels 9:107-116.
9. Chidiac P, Hebert TE, Valiquette M, Dennis M, and Bouvier M (1994) Inverse agonist activity of β-adrenergic antagonists. Mol Pharmacol 45:490-499.
10. 4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol Pharmacol 55:910-920.
11. Clark RB and Knoll BJ (2002) Measurement of receptor desensitization and internalization in intact cells. Methods Enzymol 343:506-529.
12. 2C receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. Mol Pharmacol 62:578-589.
13. 1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein. J Biol Chem 279:34431-34439.
14. i switching. Mol Pharmacol 62:1094-1102.
15. 2. J Biol Chem 277:2614-2619.
16. 4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO (Eur Mol Biol Organ) J 14:2806-2815.
17. Guthrie CR, Murray AT, Franklin AA, and Hamblin MW (2005) Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. J Pharmacol Exp Ther 313:1003-1010.
18. 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem 264:12657-12665.
19. 7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J Neurochem 68:1372-1381.
20. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, and Humphrey PPA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
21. 7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn-Schmiedeberg's Arch Pharmacol 363:620-632.
22. 7 serotonin receptor splice variants: constitutive activity and inverse agonist effects. Br J Pharmacol 135:1563-1571.
23. Krupinski J, Lehman TC, Frankenfield CD, Zwaagstra JC, and Watson PA (1992) Molecular diversity in the adenylylcyclase family. Evidence for eight forms of the enzyme and cloning of type VI. J Biol Chem 267:24858-24862.
24. 2-adrenergic receptors. Proc Natl Acad Sci USA 90:10798-10802.
25. Mm exchange factor by muscarinic receptors and G-protein βγ subunits. Nature (Lond) 382:268-272.
26. Mattingly RR, Sorisky A, Brann MR, and Macara IG (1994) Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain. Mol Cell Biol 14:7943-7952.
27. 1 cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Mol Pharmacol 57:162-170.
28. Norum JH, Méthi T, Mattingly RR, and Levy FO (2005) Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells. FEBS J 272:2304-2316.
29. Ostrom RS, Violin JD, Coleman S, and Insel PA (2000) Selective enhancement of β-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol 57:1075-1079.
30. Post SR, Hilal-Dandan R, Urasawa K, Brunton LL, and Insel PA (1995) Quantification of signalling components and amplification in the β-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J 311 (Pt 1):75-80.
31. i: precoupling and constitutive activity. Mol Pharmacol 56:1014-1024.
32. 1 using immunoaffinity chromatography: evidence for precoupling. Biochem Biophys Res Commun 290:1300-1307.
33. 3H-cAMP) ligand, or of unlabeled ligand only. Acta Pharmacol Toxicol 46:200-204.
34. 7 receptors in rodent, pig and primate brain tissues. Neuropharmacology 42:74-81.
35. Vasquez C and Lewis DL (1999) The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J Neurosci 19:9271-9280.
36. Weiss JM, Morgan PH, Lutz MW, and Kenakin TP (1996) The cubic ternary complex receptor occupancy model. I. Model description. J Theor Biol 178:151-167.